Resources
-
Introduction to the EFPIA Manufacturing and Quality Expert Group (MQEG) - Biomanufacturing WG Satellite Session 2024
Speaker Presentation CMC Europe 2024
Goese Markus, F. Hoffman-La Roche Ltd., 2024 -
Use of Multi-Attribute-Method by Mass Spectrometry as a QC Release and Stability Tool for Biopharmaceuticals – the EFPIA Perspective
Speaker Presentation CMC Europe 2024
Gervais Annick, UCB Pharma S.A., 2024 -
Multiproduct Resin Reuse (MRR) Strategy in Clinical Development
Speaker Presentation CMC Europe 2024
Frey Claudia, Merck Sharp & Dohme UK Limited, 2024 -
Use of Third Party Prior Knowledge and Platform Data
Speaker Presentation CMC Europe 2024
Ford Gair, AstraZeneca, 2024 -
Regulating AI in Drug Manufacturing
Speaker Presentation CMC Europe 2024
Fisher Adam, CDER, FDA, 2024 -
EU GMPs Annex 1: 2022 - New Role of the Microbiologists on Aseptic Processes
Speaker Presentation CMC Europe 2024
Dalmaso Gilberto, GDM Pharma Consulting, 2024 -
Application of ICH Q2/Q14 to Procedure Development and Changes for Monoclonal Antibodies and Gene Therapy Products
Speaker Presentation CMC Europe 2024
Chéry Cyrille, UCB Pharma S.A., 2024 -
PACMPs: Best Practices, and Future Opportunities
Speaker Presentation CMC Europe 2024
Chauhan Vandana, Gilead Sciences, Inc., 2024 -
Navigating Challenges in Subcutaneous Biologics: Advancing High and Ultra-High Concentration Technologies with a Patient-Centric Approach
Speaker Presentation CMC Europe 2024
Bechtold-Peters Karoline, Novartis Pharma AG, 2024 -
Industry Perspective on the Use of Post-Approval Change Management Protocol
Speaker Presentation CMC Europe 2024
Basu Sen Shrobona, Novo Nordisk A/S, 2024 -
Rethinking Biosimilar Approval: A Future Without Phase 3 Trials?
Speaker Presentation CMC Europe 2024
Barry Sean, Health Products Regulatory Authority, 2024 -
Navigating the Evolving ICH Regulatory Landscape: A Regulator’s Perspective
Speaker Presentation CMC Europe 2024
Barry Sean, Health Products Regulatory Authority, 2024 -
CMC Europe 2024 Scientific Program
Scientific Program: CMC Europe 2024
-
CMC Europe 2024 Summary Infographic
Summary Infographic: CMC Europe 2024
-
CE Pharm 2024 Summary Infographic
Summary Infographic: CE Pharm 2024
-
Role of CE for Therapeutic Nucleic Acids: Gene Therapy and Vaccines
Roundtable Session 1 Table 8 CE Pharm 2024
-
Peak Integration in CE
Roundtable Session 2 Table 8 CE Pharm 2024
-
Life Cycle Management of CE Technology
Roundtable Session 1 Table 9 CE Pharm 2024
-
Is High Throughput Always Better?
Roundtable Session 1 Table 7 CE Pharm 2024
-
iCIEF - Becoming the CE Expert in Your Organization – Best Practices Exchange [Session 2]
Roundtable Session 2 Table 3 CE Pharm 2024